Intradermal immunization-a dose-sparing strategy to combat global shortages of severe acute respiratory syndrome coronavirus 2 vaccines?

Jenny L Schnyder; Hanna K de Jong; Martin P Grobusch

doi:10.1016/j.cmi.2021.08.020

Intradermal immunization-a dose-sparing strategy to combat global shortages of severe acute respiratory syndrome coronavirus 2 vaccines?

Clin Microbiol Infect. 2022 Jan;28(1):6-8. doi: 10.1016/j.cmi.2021.08.020. Epub 2021 Aug 29.

Authors

Jenny L Schnyder¹, Hanna K de Jong¹, Martin P Grobusch²

Affiliations

¹ Centre for Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Division of Internal Medicine, Amsterdam UMC, Amsterdam Infection & Immunity, Amsterdam Public Health, University of Amsterdam, Amsterdam, the Netherlands.
² Centre for Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Division of Internal Medicine, Amsterdam UMC, Amsterdam Infection & Immunity, Amsterdam Public Health, University of Amsterdam, Amsterdam, the Netherlands; Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany; Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Centre de Recherches Médicales en Lambaréné (CERMEL), Lambaréné, Gabon; Masanga Medical Research Unit (MMRU), Masanga, Sierra Leone. Electronic address: [email protected].

No abstract available

Keywords: Coronavirus disease 2019; Dose-sparing strategy; Intradermal immunization; Severe acute respiratory syndrome coronavirus 2; Vaccine shortage.

MeSH terms

Adaptive Immunity
Antigen-Presenting Cells / immunology
COVID-19 Vaccines* / administration & dosage
COVID-19 Vaccines* / supply & distribution
COVID-19* / prevention & control
Humans
Injections, Intradermal*
Randomized Controlled Trials as Topic
Vaccination / methods*

Substances

COVID-19 Vaccines